Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.52
(
-1.51%
)
US TECH 100
23,203.60
(
-2.18%
)
Dow Jones
45,578.24
(
-0.96%
)
Brent Oil
107.90
(
3.32%
)
Bitcoin
70,136.64
(
0.34%
)
News Focus
News Focus
Post# of 257263
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 212357

Thursday, 07/13/2017 10:09:01 AM

Thursday, July 13, 2017 10:09:01 AM

Post# of 257263
Re: CAR-T /MNTA

Besides the approx $500k for the initial treatment, the patients' immune system will be crippled. The patients will need boosting immunoglobulin treatment every 3 to 4 weeks (possibly for life) at a cost of about $10K per treatment.

MNTA’s M254 (hyper-sialylated Fc—a cheaper, recombinant alternative to plasma-derived IVIG) could potentially help with this problem.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today